Addition of clinical trials company expands MPI Research capabilities to include human Phase I testing.
MPI Research announced it has acquired the assets of Kalamazoo, Mich.-based Jasper Clinical Research & Development, Inc., a clinical research organization that provides early-stage human clinical testing of new drugs.
The acquisition includes the Jasper Clinic, a 50-bed clinical trial unit that provides early-stage study services, including pharmacokinetic and pharmacodynamics, drug interaction and methodology studies, and expertise in integrating pharmacogenetics and biomarkers into studies. The three-story, 25,000-square-foot clinic is located on the downtown Kalamazoo campus of Bronson Hospital, and is physically connected to Bronson’s Level 1 trauma center.
The acquisition marks the second service expansion by MPI Research in the past year. In May 2014, the company, along with partners inviCRO and 3D Imaging, opened the Translational Imaging Center, which includes a cyclotron, specialized services, and is connected to a vivarium. This facility and the expertise associated with it will permit drug radiolabeling and in-depth distribution studies across a wide variety of animal and human models, MPI reports in a statement.
Source: MPI Research